Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.
- NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_assertion description "[The expression of the two most commonly expressed CT genes on the arrays, MAGEA9 (24 of 122 cancers and 0 of 10 normal tissues) and Down syndrome critical region 8 (DSCR8)/MMA1 (16 if 122 cancers and 0 of 10 normal tissues), was confirmed by reverse transcription-PCR methods, validating the array screening approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.
- NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_assertion evidence source_evidence_literature NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.
- NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_assertion SIO_000772 17363524 NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.
- NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_assertion wasDerivedFrom befree-20140225 NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.
- NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_assertion wasGeneratedBy ECO_0000203 NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP915407.RA5EOYJkSVeJEaxOz_UHk_5eS063nyfkNh2P3gHghEba4130_provenance.